Get the latest tech news
Millions in west don't know they have aggressive fatty liver disease, study says
Research finds more than 15m in US, UK, Germany and France with MASH have not been diagnosed
The report, published in the Lancet Regional Health Europe and presented at the meeting of the global thinktank on steatotic liver disease in Barcelona, Spain, on Thursday, calls for a doubling in diagnosis rates from 2022 levels. Responding to the findings, Emmanouil Tsochatzis, a professor of hepatology at University College London and a consultant hepatologist at the Royal Free hospital, said: “More than 15 million people across the US and Europe have the deadliest form of fatty liver disease – and don’t know it. Dr Paul Brennan, a co-author of the Lancet paper and a hepatologist at NHS Tayside, said: “GLP-1s (including Wegovy and Mounjaro) offer the potential to resynchronise our metabolism, by introducing feelings of satiety – fullness – and delaying the time the stomach takes to empty.
Or read this on Hacker News
